The cost sure doesn't worry me after this experience.
I'm now convinced that a change of mgmt is more important than a Nasdaq listing.
What rotten luck to be stuck with PC.
The turndown of GSK 100 million settlement was the first warning sign and no excuse about the board making the decision. A strong CEO directs the board.
Oh well. That's about it from me. Punch drunk.